Patients with type 1 diabetes in a tertiary setting do not attain recommended lipid targets - 11/09/20
Doi : 10.1016/j.diabet.2018.12.002
N.S.R. Lan a, ⁎ 
, B.B. Yeap a, b, D.A. Bell b, c, d, G.F. Watts b, d, P.G. Fegan a
, B.B. Yeap a, b, D.A. Bell b, c, d, G.F. Watts b, d, P.G. Fegan a a Department of Endocrinology and Diabetes, Fiona Stanley Hospital, 11 Robin Warren Drive, 6150 Murdoch, Western Australia, Australia
b Medical School, University of Western Australia, 35, Stirling Highway, Crawley, 6009 Western Australia, Australia
c Department of Clinical Biochemistry, PathWest Laboratory Medicine, Royal Perth and Fiona Stanley Hospitals, 11, Robin Warren Drive, Murdoch, 6150 Western Australia, Australia
d Department of Cardiology, Lipid Disorders Clinic, Cardiometabolic Service, Royal Perth Hospital, 197, Wellington street, Perth, 6000 Western Australia, Australia
⁎Corresponding author at: Department of Endocrinology and Diabetes, Fiona Stanley Hospital, 11, Robin Warren Drive, Murdoch, 6150 Western Australia, Australia.Department of Endocrinology and Diabetes, Fiona Stanley Hospital11, Robin Warren DriveMurdochWestern Australia6150Australia
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Le texte complet de cet article est disponible en PDF.
Plan
© 2018
Elsevier Masson SAS. Tous droits réservés.
Vol 46 - N° 4
P. 339-341 - septembre 2020 Retour au numéro
Article précédent
- Metformin misuse in chronic kidney disease
- V. Coliche, L. Koppe, M. Laville, M. Nouvier, S. Pelletier, P. Trolliet, D. Fouque
- Severely uncontrolled diabetes: a new aetiology of acquired bisalbuminaemia
- Alexandre Lugat, Hélène Caillon, Lucy Chaillous, Bertrand Cariou, Delphine Drui
Bienvenue sur EM-consulte, la référence des professionnels de santé.